Hormone replacement therapy: Current controversies [1]

Clinical Endocrinology

Volumn 59, Issue 5, 2003, Pages 657-

  Orija, I B ^a   Mehta, A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GLUCOSE; MEDROXYPROGESTERONE ACETATE;

DIABETES MELLITUS; ESTROGEN DEFICIENCY; ESTROGEN THERAPY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0242320249     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01833.x     Document Type: Letter

References (3)

1. Davison, S. & Davis, S.R. (2003) Hormone replacement therapy: current controversies. Clinical Endocrinology, 58, 249-261.
2. Kanaya, A.M., Herrington, D., Vittinghoff, E., Lin, F., Grady, D., Bittner, V. et al. (2003) Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Annals of Internal Medicine, 138, 1-9.
3. Manson, J.E., Rimm, E.B., Colditz, G.A., Willett, W.C., Nathan, D.M., Arky, R.A. et al. (1992) A prospective study of postmenopausal estrogen therapy and subsequent incidence of noninsulin-dependent diabetes mellitus. Annals of Epidemiology, 2, 665-673.